Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare and digital health company focused on portable, semiconductor-based ultrasound technology and ultrasound software solutions. The Butterfly Network news feed on Stock Titan highlights company announcements that relate to its handheld ultrasound devices, Ultrasound-on-Chip™ semiconductor platform, enterprise software and AI initiatives.
Investors and healthcare professionals following BFLY news will see updates on financial results and guidance, such as quarterly earnings releases and preliminary revenue expectations furnished through press releases and 8-K filings. These items often include commentary on revenue growth, cash usage, chip development milestones and the progress of enterprise offerings like Compass™ and Compass AI™.
News coverage also features product and platform developments, including launches of new software capabilities such as Compass AI, announcements about AI-enabled clinical tools like Auto B-line Counter or a Gestational Age AI tool, and information about developer-focused initiatives like Butterfly Garden™ and the planned Beam Steering API. These stories provide insight into how Butterfly is expanding its imaging platform and exposing core capabilities to partners and developers.
Another recurring theme in Butterfly Network news is global health and clinical impact. Press releases describe programs in Sub-Saharan Africa involving handheld probes, training and AI tools for obstetric ultrasound, as well as clinical publications that examine how Butterfly’s devices and software can affect workflows, costs and provider economics in hospital systems.
In addition, the BFLY news stream includes capital markets and corporate updates, such as participation in healthcare investor conferences, executive appointments and SEC-reported events like the NYSE’s decision to delist Butterfly’s public warrants while leaving the common stock listing under BFLY unchanged. For readers tracking Butterfly Network, this page offers a consolidated view of operational, financial, technological and regulatory developments as they are publicly disclosed.
Butterfly Network, Inc. (NYSE: BFLY) announced the completion of its business combination with Longview Acquisition Corp. (NYSE: LGVW, LGVW.U), approved by stockholders on February 12, 2021. This transaction, which closed on February 16, 2021, provided the company with approximately $589 million in cash, enhancing its efforts to democratize medical imaging. Butterfly's innovative ultrasound technology aims to improve healthcare delivery and expand market applications, notably in chronic disease management affecting over 100 million patients in the U.S. The company reported 2020 revenues of at least $45 million, a 63% growth over 2019.
Summary not available.
Summary not available.
Butterfly Network, an innovative digital health company, is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 9:30 AM ET. The company will discuss its plans to enhance access to ultrasound technology. Butterfly Network will be listed on the NYSE under the ticker BFLY following a merger with Longview Acquisition Corp (NYSE: LGVW). The leadership team, including CEO Laurent Faracci and CMO Dr. John Martin, aims to democratize medical imaging globally, particularly for the 4.7 billion people currently lacking ultrasound access.